36 results about "Specific antibody level" patented technology

This invention relates to methods that enable the detection of antibodies against a latent infection, a chronic infection, a re-infection, and / or a breakthrough infection; enable the diagnosis of a latent infection, a chronic infection, a re-infection, and / or a breakthrough infection; and increase low anti-viral antibody levels, and a kit for the detection of virus-specific antibodies expressed at low levels.

The invention discloses beta-1,3-D-glucan modified biomimetic hollow silicon dioxide composite particles and application thereof. The composite particles are obtained by performing a coupling reactionon biomimetic hollow silicon dioxide particles and beta-1,3-D-glucan, wherein the pore diameter range of nanometer transmission pore passages of the biomimetic hollow silicon dioxide particles is 1.7-15.2nm. The composite particles have the morphologies of bacteria and the nanometer transmission pore passages with appropriate pore diameter distribution, facilitate passing of antigens and medicines with different molecular weights, have relatively high antigen loading capacity, can continuously release the antigens, can increase the antigen utilization rate, reduce the number of injections andreduce toxic and side effects of the antigens and vaccine adjuvants, and continuously provides an immunoprotective effect; the composite particles have the equivalent level of inducing antigen-specific antibodies to an aluminum adjuvant and a Freund's adjuvant, and have a wide application prospect in the biomedical field; in addition, the composite particles is simple in preparation method, low in cost, environment-friendly and low in preparation cost, and have an industrial production potential.

The invention discloses a reagent for detecting specific immune response of mycobacterium tuberculosis and use thereof. The invention discloses an immune positive reagent Rv0733 of mycobacterium tuberculosis by a gamma interferon release assay and a serum enzyme-linked immune method. The reagent comprises antigen or polypeptide and analogues thereof for detecting the specific cellular immunity of a tuberculosis sufferer and humoral immune response level. After the mice are immunized by using the reagent disclosed by the invention, the mice can generate specific cell factors such as gamma interferon and the like, and an antibody. T cells of tuberculosis patients or normal people are stimulated by using the reagent in vitro, the quantity of gamma interferon release cells is detected, or the content of gamma interferon in supernatant is cultivated, the tuberculosis patients can be distinguished from the normal people, the detection sensitivity and specificity of the tuberculosis sufferer can be improved by detecting the specific antibody level of resisting the reagent in the peripheral serum, and the clinical prognosis conditions of the tuberculosis patients can be disclosed by utilizing an Rv0733 specific immune response contrast experiment in the process of tracking treatment of the tuberculosis sufferer.

A homogeneous immunoassay method and system for quantitative determination of total immunoglobulin E and specific antibody levels to a plurality of allergens, in which a relatively small sampling of blood is required. The method utilizes relatively small microparticles in aqueous suspension. The immunoassay procedure is an immunometric sandwich procedure preferably utilizing biotin-streptavidin signal amplification techniques and R-phycoerytherin fluorescent labels.